Efficacy and safety of aumolertinib as second- or third-line therapy in EGFR T790M negative/unknown non-small cell lung cancer
Aumolertinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Efficacy and safety of aumolertinib as second- or third-line therapy in EGFR T790M negative/unknown non-small cell lung cancer ### Output: Aumolertinib